Zobrazeno 1 - 10
of 19
pro vyhledávání: '"W Almajed"'
Publikováno v:
The Journal of Sexual Medicine. 20
Introduction As the population ages, the prevalence of age-related hypogonadism is expected to rise. Demand for testosterone replacement therapy (TRT) has increased, as evidenced by revenue from T prescriptions in the world increasing from $150 milli
Publikováno v:
The Journal of Sexual Medicine. 20
Introduction The incidence of Peyronie's disease (PD) is 4% in the U.S. male population. Many PD patients also suffer from erectile dysfunction (ED). The etiology of ED incidence in PD men is not known, although veno-occlusive dysfunction (VOD) is of
Autor:
S Caputo, G Blair, G Hampel, J Greenberg, B Herzog, T Nguyen, W Almajed, S Sikka, W Hellstrom
Publikováno v:
The Journal of Sexual Medicine. 20
Introduction The IMPRESS trial revealed that intralesional collagenase clostridium histolyticum, Xiaflex, is safe and efficacious for treating the physical and subjective effects of Peyronie’s Disease (PD). However, little is known about the other
Autor:
JW Greenberg, A Soubra, J Kim, J Pincus, N Ottaiano, C Natale, HMT Nguyen, ML Sandberg, W Almajed, S Sikka, WJ Hellstrom
Publikováno v:
The Journal of Sexual Medicine. 19:S38-S39
Introduction Peyronie's Disease (PD) is characterized by physical deformity in the penis that often has a negative impact on the sexual relationship of the patient and his partner. The International Index of Erectile Function (IIEF) is a standardized
Autor:
JW Greenberg, A Soubra, J Kim, J Pincus, N Ottaiano, C Natale, HMT Nguyen, J Tannenbaum, ML Sandberg, W Almajed, S Sikka, WJ Hellstrom
Publikováno v:
The Journal of Sexual Medicine. 19:S36-S37
Introduction One of the main complaints of patients with Peyronie's Disease (PD), besides the curvature, is penile shrinkage. Both deformities result in significant distress to the patient and his partner. XIAFLEX has been developed to treat Peyronie
Autor:
J Kim, A Soubra, H Kim, J Greenberg, N Ottaiano, R Morenas, B Chacko, W Wisen, N Fatima, B Dick, S Halat, W Almajed, O Raheem, A Abdel-Mageed, W Hellstrom
Publikováno v:
The Journal of Sexual Medicine. 19:S33-S33
Introduction Low-intensity extracorporeal shockwave therapy (Li-ESWT) is postulated to have physiologic effects including neo-angiogenesis, upregulation of vasoactive endothelial growth factors, nerve recovery, reduction of fibrotic changes, cavernos
Autor:
A Soubra, JW Greenberg, J Kim, C Natale, J Pincus, N Ottaiano, HMT Nguyen, W Almajed, S Sikka, WJ Hellstrom
Publikováno v:
The Journal of Sexual Medicine. 19:S39-S39
Introduction Peyronie's Disease (PD) is a localized disease of the Tunica albuginea (TA) characterized by the formation of fibrotic plaque. Patients with PD present with erectile dysfunction (ED) up to 32% of the time. We have presented in previous s
Autor:
A Soubra, J Kim, H Kim, J Greenberg, N Ottaiano, R Morenas, B Chacko, W Wisen, N Fatima, B Dick, S Halat, W Almajed, O Raheem, A Abdel-Mageed, W Hellstrom
Publikováno v:
The Journal of Sexual Medicine. 19:S28-S28
Introduction Low-intensity extracorporeal shockwave therapy (Li-ESWT) may have physiologic effects including neo-angiogenesis, upregulation of vasoactive endothelial growth factors, nerve recovery, reduction of fibrotic changes, cavernosal tissue rem
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.